As of 2025-11-01, the Relative Valuation of Dyne Therapeutics Inc (DYN) is (62.59) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.55 USD, the upside of Dyne Therapeutics Inc based on Relative Valuation is -365.8%.
The range of the Relative Valuation is (62.20) - (62.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.2x - 15.4x | 15.3x |
| Forward P/E multiples | 15.2x - 15.3x | 15.2x |
| Fair Price | (62.20) - (62.86) | (62.59) |
| Upside | -364.1% - -366.9% | -365.8% |
| Date | P/E |
| 2025-10-30 | -5.75 |
| 2025-10-29 | -5.77 |
| 2025-10-28 | -5.93 |
| 2025-10-27 | -5.90 |
| 2025-10-24 | -4.18 |
| 2025-10-23 | -4.02 |
| 2025-10-22 | -3.99 |
| 2025-10-21 | -4.09 |
| 2025-10-20 | -4.17 |
| 2025-10-17 | -4.00 |
| 2025-10-16 | -4.01 |
| 2025-10-15 | -4.03 |
| 2025-10-14 | -3.77 |
| 2025-10-13 | -3.42 |
| 2025-10-10 | -3.43 |
| 2025-10-09 | -3.58 |
| 2025-10-08 | -3.55 |
| 2025-10-07 | -3.40 |
| 2025-10-06 | -3.09 |
| 2025-10-03 | -3.19 |
| 2025-10-02 | -3.06 |
| 2025-10-01 | -3.05 |
| 2025-09-30 | -3.09 |
| 2025-09-29 | -3.02 |
| 2025-09-26 | -3.21 |
| 2025-09-25 | -3.07 |
| 2025-09-24 | -3.21 |
| 2025-09-23 | -3.22 |
| 2025-09-22 | -3.28 |
| 2025-09-19 | -3.20 |
| 2025-09-18 | -3.40 |
| 2025-09-17 | -3.21 |
| 2025-09-16 | -3.17 |
| 2025-09-15 | -3.14 |
| 2025-09-12 | -3.21 |
| 2025-09-11 | -3.22 |
| 2025-09-10 | -3.24 |
| 2025-09-09 | -3.23 |
| 2025-09-08 | -3.25 |
| 2025-09-05 | -3.47 |
| 2025-09-04 | -3.23 |
| 2025-09-03 | -3.29 |
| 2025-09-02 | -3.29 |
| 2025-08-29 | -3.29 |
| 2025-08-28 | -3.36 |
| 2025-08-27 | -3.33 |
| 2025-08-26 | -3.27 |
| 2025-08-25 | -3.17 |
| 2025-08-22 | -3.07 |
| 2025-08-21 | -2.98 |